175 related articles for article (PubMed ID: 23018122)
1. Differential sensitivity of cranial and limb motor function to nigrostriatal dopamine depletion.
Plowman EK; Maling N; Rivera BJ; Larson K; Thomas NJ; Fowler SC; Manfredsson FP; Shrivastav R; Kleim JA
Behav Brain Res; 2013 Jan; 237():157-63. PubMed ID: 23018122
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopamine depletion induces forelimb motor impairments and disrupts forelimb movement representations within the motor cortex.
Plowman EK; Thomas NJ; Kleim JA
J Parkinsons Dis; 2011; 1(1):93-100. PubMed ID: 23939260
[TBL] [Abstract][Full Text] [Related]
3. Targeted motor rehabilitation dissociates corticobulbar versus corticospinal dysfunction in an animal model of Parkinson's disease.
Plowman EK; Maling N; Thomas NJ; Fowler SC; Kleim JA
Neurorehabil Neural Repair; 2014 Jan; 28(1):85-95. PubMed ID: 23921422
[TBL] [Abstract][Full Text] [Related]
4. Sequential bilateral striatal lesions have additive effects on single skilled limb use in rats.
Faraji J; Metz GA
Behav Brain Res; 2007 Feb; 177(2):195-204. PubMed ID: 17182115
[TBL] [Abstract][Full Text] [Related]
5. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
[TBL] [Abstract][Full Text] [Related]
6. Relationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion.
Grant LM; Barnett DG; Doll EJ; Leverson G; Ciucci M
Behav Brain Res; 2015 Sep; 291():361-371. PubMed ID: 26026785
[TBL] [Abstract][Full Text] [Related]
7. A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study.
Healy-Stoffel M; Ahmad SO; Stanford JA; Levant B
J Neurosci Methods; 2012 Sep; 210(2):187-94. PubMed ID: 22850559
[TBL] [Abstract][Full Text] [Related]
8. Tongue force and tongue motility are differently affected by unilateral vs bilateral nigrostriatal dopamine depletion in rats.
Nuckolls AL; Worley C; Leto C; Zhang H; Morris JK; Stanford JA
Behav Brain Res; 2012 Oct; 234(2):343-8. PubMed ID: 22796604
[TBL] [Abstract][Full Text] [Related]
9. Nasal application of kisspeptin-54 mitigates motor deficits by reducing nigrostriatal dopamine loss in hemiparkinsonian rats.
Sinen O; Sinen AG; Derin N; Aslan MA
Behav Brain Res; 2024 Jun; 468():115035. PubMed ID: 38703793
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
Matsuura K; Makino H; Ogawa N
Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
[TBL] [Abstract][Full Text] [Related]
11. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways.
Roedter A; Winkler C; Samii M; Walter GF; Brandis A; Nikkhah G
J Comp Neurol; 2001 Apr; 432(2):217-29. PubMed ID: 11241387
[TBL] [Abstract][Full Text] [Related]
12. Effects of calpain inhibition on dopaminergic markers and motor function following intrastriatal 6-hydroxydopamine administration in rats.
Grant RJ; Sellings LH; Crocker SJ; Melloni E; Park DS; Clarke PB
Neuroscience; 2009 Jan; 158(2):558-69. PubMed ID: 19007862
[TBL] [Abstract][Full Text] [Related]
13. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance.
Metz GA; Whishaw IQ
Neuroscience; 2002; 111(2):325-36. PubMed ID: 11983318
[TBL] [Abstract][Full Text] [Related]
15. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.
Chen L; Deltheil T; Turle-Lorenzo N; Liberge M; Rosier C; Watabe I; Sreng L; Amalric M; Mourre C
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1295-306. PubMed ID: 24661728
[TBL] [Abstract][Full Text] [Related]
16. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.
Kirik D; Rosenblad C; Björklund A
Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582
[TBL] [Abstract][Full Text] [Related]
17. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
[TBL] [Abstract][Full Text] [Related]
19. Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease.
Metz GA; Piecharka DM; Kleim JA; Whishaw IQ
Brain Res; 2004 Nov; 1026(1):126-35. PubMed ID: 15476704
[TBL] [Abstract][Full Text] [Related]
20. Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.
Ariano MA; Grissell AE; Littlejohn FC; Buchanan TM; Elsworth JD; Collier TJ; Steece-Collier K
J Neurosci Res; 2005 Nov; 82(3):387-96. PubMed ID: 16180225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
